# AZD8186 and Paclitaxel in Advanced Gastric Cancer

> **NCT04001569** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Seoul National University Bundang Hospital** · enrollment: 49 (estimated)

## Conditions studied

- Solid Tumor
- Stomach Cancer

## Interventions

- **DRUG:** AZD8186 in combination with paclitaxel

## Key facts

- **NCT ID:** NCT04001569
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-14
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2019-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04001569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04001569, "AZD8186 and Paclitaxel in Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04001569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*